Literature DB >> 20156923

Circadian rhythm of serum vaspin in healthy male volunteers: relation to meals.

Eunheui Jeong1, Byung-Soo Youn, Dong Woo Kim, Eun Hee Kim, Ji Woo Park, Churl Namkoong, Ji Yun Jeong, So Yoon Yoon, Joong Yeol Park, Ki-Up Lee, Min-Seon Kim.   

Abstract

CONTEXT: Visceral adipose tissue-derived serine protease inhibitor (vaspin) is a novel adipokine with insulin-sensitizing effects. However, the physiological role for vaspin in human metabolic regulation remains to be established.
OBJECTIVE: We studied the 24-h profiles of circulating vaspin concentrations in relation to meal ingestion in normal adults.
DESIGN: Blood samples were drawn 39 times throughout a 24-h period from 10 healthy male subjects provided with meals on a fixed schedule. On a separate day, four subjects were fasted and then provided with an unexpected meal to clarify the effect of meal consumption on serum vaspin levels. Serum vaspin concentrations were determined by ELISA.
RESULTS: Serum vaspin levels were highest in the early morning before breakfast and fell to trough levels within 2 h after breakfast. Serum vaspin levels also showed a preprandial rise and postprandial fall at lunch and dinner, although at lesser degrees than at breakfast. Intermeal vaspin concentrations reached a nadir in the mid-afternoon and showed a nocturnal rise, with peak nighttime vaspin levels being approximately 250% of nadir levels. Unscheduled food ingestion after a prolonged fast significantly reduced serum vaspin levels, suggesting that energy intake itself has a suppressive effect on serum vaspin levels. The diurnal pattern of serum vaspin concentrations was exactly reciprocal to that of insulin and of glucose.
CONCLUSION: Serum vaspin levels have a meal-related diurnal variation, suggesting a role for vaspin in metabolic regulation. However, the reciprocal relationship between serum vaspin and insulin may negate the importance of vaspin as an physiological insulin sensitizer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20156923     DOI: 10.1210/jc.2009-1088

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

Review 1.  [Adipokines in healthy and obese children].

Authors:  G A Martos-Moreno; J J Kopchick; J Argente
Journal:  An Pediatr (Barc)       Date:  2012-11-24       Impact factor: 1.500

Review 2.  Vaspin in obesity and diabetes: pathophysiological and clinical significance.

Authors:  Matthias Blüher
Journal:  Endocrine       Date:  2011-12-03       Impact factor: 3.633

3.  Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans.

Authors:  Eun Seok Kang; Faidon Magkos; Elizabeth Sienkiewicz; Christos S Mantzoros
Journal:  Eur J Endocrinol       Date:  2011-03-21       Impact factor: 6.664

4.  Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects.

Authors:  N Klöting; P Kovacs; M Kern; J T Heiker; M Fasshauer; M R Schön; M Stumvoll; A G Beck-Sickinger; M Blüher
Journal:  Diabetologia       Date:  2011-04-05       Impact factor: 10.122

5.  Analysis of a rare functional truncating mutation rs61757459 in vaspin (SERPINA12) on circulating vaspin levels.

Authors:  Jana Breitfeld; John T Heiker; Yvonne Böttcher; Dorit Schleinitz; Anke Tönjes; Kerstin Weidle; Kerstin Krause; E Bartholomeus Kuettner; Markus Scholz; Wieland Kiess; Norbert Sträter; Annette G Beck-Sickinger; Michael Stumvoll; Antje Körner; Matthias Blüher; Peter Kovacs
Journal:  J Mol Med (Berl)       Date:  2013-06-12       Impact factor: 4.599

6.  Various oscillation patterns of serum fibroblast growth factor 21 concentrations in healthy volunteers.

Authors:  Sang Ah Lee; Eunheiu Jeong; Eun Hee Kim; Mi-Seon Shin; Jenie Yoonoo Hwang; Eun Hee Koh; Woo Je Lee; Joong-Yeol Park; Min-Seon Kim
Journal:  Diabetes Metab J       Date:  2012-02-17       Impact factor: 5.376

Review 7.  The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis.

Authors:  Rumyana Dimova; Tsvetalina Tankova
Journal:  Biomed Res Int       Date:  2015-04-06       Impact factor: 3.411

8.  The serum vaspin levels are reduced in Japanese chronic hemodialysis patients.

Authors:  Junko Inoue; Jun Wada; Sanae Teshigawara; Kazuyuki Hida; Atsuko Nakatsuka; Yuji Takatori; Shoichirou Kojo; Shigeru Akagi; Kazushi Nakao; Nobuyuki Miyatake; John F McDonald; Hirofumi Makino
Journal:  BMC Nephrol       Date:  2012-12-03       Impact factor: 2.388

9.  Vaspin inhibits kallikrein 7 by serpin mechanism.

Authors:  John T Heiker; Nora Klöting; Peter Kovacs; E Bartholomeus Kuettner; Norbert Sträter; Stephan Schultz; Matthias Kern; Michael Stumvoll; Matthias Blüher; Annette G Beck-Sickinger
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

10.  Role of vaspin in human eating behaviour.

Authors:  Jana Breitfeld; Anke Tönjes; Marie-Therese Gast; Dorit Schleinitz; Matthias Blüher; Michael Stumvoll; Peter Kovacs; Yvonne Böttcher
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.